Foamix Pharmaceuticals Ltd. Operating Income
Foamix Pharmaceuticals Ltd. reported Operating Income of -$37.43 million for the 3-month period ending 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2020-03-12
- Foamix Pharmaceuticals Ltd. operating income (loss) for the quarter ending 2019-12-31 was -$37.43M.
- Foamix Pharmaceuticals Ltd. operating income (loss) for the quarter ending 2019-09-30 was -$23.20M.
- Foamix Pharmaceuticals Ltd. operating income (loss) for the quarter ending 2019-06-30 was -$19.36M.
- Foamix Pharmaceuticals Ltd. operating income (loss) for the quarter ending 2019-03-31 was -$15.88M.
- Foamix Pharmaceuticals Ltd. operating income (loss) for fiscal 2019 was -$95.87M.
- Foamix Pharmaceuticals Ltd. operating income (loss) for fiscal 2018 was -$74.89M.
- Foamix Pharmaceuticals Ltd. operating income (loss) for fiscal 2017 was -$65.61M.
- Foamix Pharmaceuticals Ltd. operating income (loss) for fiscal 2016 was -$29.65M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2019-12-31 | -$37.43M 10-K · filed 2020-03-12 | -$60.63M derived: sum of 2 quarters · filed 2020-03-12 | -$79.99M derived: sum of 3 quarters · filed 2020-03-12 | -$95.87M 10-K · filed 2020-03-12 | |
| 2019-09-30 | -$23.20M 10-K · filed 2020-03-12 | -$42.56M derived: sum of 2 quarters · filed 2020-03-12 | -$58.44M 10-Q · filed 2019-11-12 | -$73.24M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2019-06-30 | -$19.36M 10-K · filed 2020-03-12 | -$35.24M 10-Q · filed 2019-08-07 | -$50.04M derived: sum of 3 quarters · filed 2020-03-12 | -$65.63M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2019-03-31 | -$15.88M 10-K · filed 2020-03-12 | -$30.68M derived: sum of 2 quarters · filed 2020-03-12 | -$46.27M derived: sum of 3 quarters · filed 2020-03-12 | -$65.06M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-12-31 | -$14.80M 10-K · filed 2020-03-12 | $14.80M 10-K · filed 2019-02-28 | -$30.39M derived: sum of 2 quarters · filed 2020-03-12 | -$49.17M derived: sum of 3 quarters · filed 2020-03-12 | -$74.89M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$15.59M 10-K · filed 2020-03-12 | -$34.37M derived: sum of 2 quarters · filed 2020-03-12 | -$60.09M 10-Q · filed 2019-11-12 | -$43.47M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-06-30 | -$18.79M 10-K · filed 2020-03-12 | -$44.51M 10-Q · filed 2019-08-07 | -$27.88M derived: sum of 3 quarters · filed 2020-03-12 | -$10.06M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2018-03-31 | -$25.72M 10-K · filed 2020-03-12 | -$9.10M derived: sum of 2 quarters · filed 2020-03-12 | $8.73M derived: sum of 3 quarters · filed 2020-03-12 | $25.32M derived: sum of 4 quarters · filed 2020-03-12 | |
| 2017-12-31 | $16.62M 10-K · filed 2019-02-28 | $34.45M derived: sum of 2 quarters · filed 2019-02-28 | $51.04M derived: sum of 3 quarters · filed 2019-02-28 | -$65.61M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $17.83M 10-K · filed 2019-02-28 | $34.42M derived: sum of 2 quarters · filed 2019-02-28 | -$48.99M 10-Q · filed 2018-11-07 | $60.01M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | $16.59M 10-K · filed 2019-02-28 | -$16.59M 6-K · filed 2017-08-08 | -$31.16M 10-Q · filed 2018-08-08 | $42.18M derived: sum of 3 quarters · filed 2019-02-28 | $48.13M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $14.57M 10-K · filed 2019-02-28 | $25.59M derived: sum of 2 quarters · filed 2019-02-28 | $31.54M derived: sum of 3 quarters · filed 2019-02-28 | $39.66M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | $11.02M 10-K · filed 2018-03-01 | $16.97M derived: sum of 2 quarters · filed 2018-03-01 | $25.09M derived: sum of 3 quarters · filed 2018-03-01 | -$29.65M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $5.95M 10-K · filed 2018-03-01 | $14.07M derived: sum of 2 quarters · filed 2018-03-01 | $18.63M derived: sum of 3 quarters · filed 2018-03-01 | ||
| 2016-06-30 | $8.12M 10-K · filed 2018-03-01 | -$8.12M 6-K · filed 2016-08-10 | -$12.68M 6-K · filed 2017-08-08 | ||
| 2016-03-31 | $4.56M 10-K · filed 2018-03-01 | ||||
| 2015-12-31 | -$16.93M 10-K · filed 2018-03-01 | ||||
| 2015-06-30 | -$4.72M 6-K · filed 2016-08-10 | -$7.79M 6-K · filed 2016-08-10 | |||
| 2014-12-31 | -$1.63M 20-F · filed 2017-02-21 | ||||
| 2014-06-30 | -$301.00K 6-K · filed 2015-10-19 | $144.00K 6-K · filed 2015-10-19 | |||
| 2013-12-31 | -$1.36M 20-F · filed 2016-03-02 | ||||
| 2012-12-31 | -$1.56M 20-F · filed 2015-03-17 |